Mercator MedSystems
San Leandro, US · Delaware corporation · 2 known investors
Find your way into Mercator MedSystems
338 people in our graph share verified history with the Mercator MedSystems team — schools, employers, funds. One of them is your warm intro.
Wesley Chanunlockedknows Kirk P. Seward · together at Massachusetts Institute of Technology (overlapped)
×10knows the team · via Massachusetts Institute of Technology
knows the team · via Lawrence Livermore National Laboratory
Mercator MedSystems develops catheter-based Micro-Infusion technologies, including the Bullfrog Micro-Infusion Device, for the local delivery of pharmacologic and biologic agents to the peripheral vasculature. The medical device company runs clinical studies in deep vein thrombosis and below-the-knee peripheral arterial disease, with applications in cardiovascular treatment and denervation for hypertension.
Founders & leadership
KP
Kirk P. SewardinCo-founder, President and CEOKirk P. Seward is co-founder, president and CEO of Mercator MedSystems, which he spun out from UC Berkeley technology. He holds 40 issued U.S. patents and 48 international patents related to micro-infusion catheter devices, and has led development of the Bullfrog, Cricket, and Blowfish catheter systems through clinical trials and regulatory submissions for applications in cardiovascular and denervation therapies.
TR
Trent ReutimanNamed on SEC filing
SB
Stephen BakerNamed on SEC filing
CC
Charles CrockerNamed on SEC filing
DW
Doug WallNamed on SEC filing
Board
NS
Investors · 2
Reported raises · per SEC filings
Form D private placements$14.3M disclosed across 1 round · 2018
▶$14.3MraisedJun 2019 · 25 investors · Other Health CareRule 506(b)
▶$14.3MraisedJun 2019 · 25 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Trent ReutimanExecutive Officer, Director
- Stephen BakerExecutive Officer
- Kirk SewardExecutive Officer
- Charles CrockerDirector
- Ned ScheetzDirector
- Doug WallDirector
- Offering amount
- $15M
- Amount sold
- $14.3M
- First sale
- May 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 4
by search overlapBioworld6 shared keywordsBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.
Merit Medical5 shared keywordsMerit Medical Systems designs, develops, manufactures and markets medical devices for interventional and diagnostic procedures. The company serves healthcare providers and clinical practitioners in the medical device industry.
Terumo5 shared keywordsTerumo Medical Corporation manufactures medical devices and healthcare products across four divisions, including interventional systems for vascular access, injection and infusion devices, drug delivery devices, and precision medicine software and care pathway consulting. It serves healthcare providers as a subsidiary of Terumo Corporation.
Rf Surgical4 shared keywordsMedtronic is a healthcare technology company that develops medical devices and technologies — including pacemakers, robotic-assisted surgery systems, and AI-driven health tools — used by doctors, scientists, and engineers to treat pain and disease. It works with clinicians to create solutions aimed at treating conditions such as AFib.
Companies competing with Mercator MedSystems for the same Google search keywords, organic and paid, via search-intersection analysis.
Non-dilutive funding · 6 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase ISTTR | 2021 | $299.7K |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2013 | $2M |
| National Institutes of Health (NIH)National Institutes of Health | Phase IISTTR | 2011 | $1.1M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2010 | $217.4K |
| National Institutes of Health (NIH)National Institutes of Health | Phase ISTTR | 2009 | $218.1K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2007 | $194.2K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
In the news
Frequently asked questions
- What does Mercator MedSystems do?
- Mercator MedSystems develops catheter-based Micro-Infusion technologies, including the Bullfrog Micro-Infusion Device, for the local delivery of pharmacologic and biologic agents to the peripheral vasculature. The medical device company runs clinical studies in deep vein thrombosis and below-the-knee peripheral arterial disease, with applications in cardiovascular treatment and denervation for hypertension.
- Who founded Mercator MedSystems?
- Mercator MedSystems was founded by Kirk P. Seward.
- Who are Mercator MedSystems's investors?
- Mercator MedSystems's investors include Aphelion Capital, Medvest Capital.
- How much funding has Mercator MedSystems raised?
- Mercator MedSystems has disclosed $14.3M raised across 1 round.
- Where is Mercator MedSystems headquartered?
- Mercator MedSystems is headquartered in San Leandro, US.